• Mutant-Specific Activation of p53Y220C via Chemically Induce

  2026-07-21

  The referenced study introduces TRAP-1, a small molecule that specifically reactivates the transcriptional function of the cancer-associated p53Y220C mutant by inducing proximity between mutant p53 and BRD4. This approach demonstrates a new paradigm in restoring tumor suppressor activity and holds promise for targeted therapeutic strategies in oncology.

• Mutant-Specific Reactivation of p53Y220C via TRAP-1 Small Mo

  2026-07-21

  The referenced study introduces TRAP-1, a small molecule that activates the cancer-associated p53Y220C mutant by inducing a ternary complex with BRD4, restoring its transcriptional function. This innovation highlights a chemically induced proximity approach for reactivating tumor suppressors, paving the way for new targeted cancer therapies.

• 5-hme-dCTP: Precision Tools for Plant Epigenetic DNA Modific

  2026-07-20

  Unlock single-base resolution insight into plant DNA hydroxymethylation with 5-hme-dCTP, optimized for high-fidelity epigenetic mapping even in low-abundance contexts. This guide delivers applied workflows, troubleshooting strategies, and the latest research advances that make APExBIO’s 5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate essential for modern gene regulation studies.

• Captopril as an ACE Inhibitor: Optimizing Hypertension and O

  2026-07-20

  Captopril’s selectivity as an ACE inhibitor empowers both cardiovascular and cancer research through precise mechanistic targeting and reproducible results. This guide distills advanced protocols, troubleshooting insights, and the latest bradykinin signaling findings to maximize experimental impact across domains.

• MK-1775 and the G2 Checkpoint: Charting Translational Succes

  2026-07-19

  Explore how MK-1775, a potent Wee1 kinase inhibitor, is reshaping strategies for translational cancer research. This thought-leadership article bridges mechanistic insights, rigorous in vitro evaluation, and actionable experimental guidance, empowering researchers to leverage cell cycle checkpoint abrogation for targeted sensitization of p53-deficient tumor cells. Drawing on recent in vitro benchmarking and competitive intelligence, we define best practices and a vision for next-generation DNA damage response inhibition.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Dise

  2026-07-18

  Ferrostatin-1 (Fer-1) is revolutionizing ferroptosis research with nanomolar efficacy and high selectivity, enabling precise dissection of iron-dependent oxidative damage pathways. This article delivers actionable protocols, troubleshooting insight, and experimental enhancements for leveraging Fer-1 across cancer, neurodegeneration, and osteoarthritis models.

• Methylation, Folate Antagonists, and Neurological Disorders

  2026-07-17

  This review by Bottiglieri et al. explores the biochemical and clinical role of methylation—specifically S-adenosylmethionine (SAMe)—in neuropsychiatric disorders. It highlights how folate and vitamin B12 deficiencies disrupt methylation in the central nervous system, contributing to conditions such as depression, dementia, and neuropathies, and discusses the implications for research using folate antagonists like methotrexate.

• Solving Lab Challenges with Anti Reverse Cap Analog (ARCA),

  2026-07-17

  This article delivers a scenario-driven, evidence-based exploration of how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G (SKU B8175) optimizes synthetic mRNA workflows in cell viability, proliferation, and cytotoxicity assays. Grounded in peer-reviewed data, it guides biomedical researchers and lab technicians through practical solutions for increased translational efficiency and reproducibility using APExBIO’s ARCA reagent.

• Cdk5 Downregulation Reverses Neuronal Ferroptosis via AMPK P

  2026-07-16

  This study reveals that inhibiting cyclin-dependent kinase 5 (Cdk5) mitigates ferroptosis in hippocampal neurons after ischemic stroke by regulating the AMP-activated protein kinase (AMPK) pathway and suppressing proinflammatory microglial activation. The findings clarify mechanistic links in neuroinflammation and offer actionable targets for neuroprotection and iron metabolism research.

• Diterpene JXE-23 Induces G2/M Arrest and Autophagy in HCC Ce

  2026-07-16

  A recent study isolated the diterpene JXE-23 from Aleuritopteris albofusca and demonstrated its selective anticancer effects in hepatocellular carcinoma (HCC) cells. JXE-23 induces G2/M cell cycle arrest and protective autophagy, offering new insights for the development of autophagy-modulating anticancer agents in HCC.

• Paroxetine Mesylate: Advanced Mechanisms and Research Protoc

  2026-07-15

  Explore Paroxetine Mesylate as a selective serotonin reuptake inhibitor with nuanced polypharmacology, including CYP2D6 and kinase inhibition. This article uniquely bridges advanced molecular insights with practical research protocols, offering actionable guidance not found in existing reviews.

• NAD+/NADH Balance Regulates Fungal Adaptation to Hypoxia

  2026-07-15

  This review dissects how NAD+/NADH homeostasis modulates metabolic adaptation to hypoxia and secondary metabolite production in filamentous fungi. The findings clarify redox-mediated metabolic shifts, informing both fungal biotechnology and disease modeling applications.

• Structural Advances in Silybin Chemistry from Milk Thistle E

  2026-07-14

  Křen et al.'s comprehensive review elucidates the structural complexity, stereochemistry, and derivatization of silybin, the principal flavonolignan in milk thistle extract. These insights underpin the rational use of silymarin in oxidative stress, cancer, and metabolic research, supporting the optimization of experimental protocols and compound selection.

• Gamithromycin (BA1074): Reliable Solutions for Respiratory P

  2026-07-14

  This article presents a scenario-driven, evidence-based exploration of Gamithromycin (SKU BA1074) for researchers conducting cell viability and respiratory infection assays. Drawing on peer-reviewed studies and validated protocols, it highlights how Gamithromycin's PK/PD properties and formulation enable reproducible, data-rich results in challenging laboratory workflows. Practical Q&A blocks address common pain points, ensuring that scientists can confidently select and deploy this macrolide antibiotic in translational research.

• Microsecond Pulsed Electric Fields Drive Cardiomyocyte Ablat

  2026-07-13

  This study demonstrates that microsecond pulsed electric fields (μsPEFs) induce targeted myocardial ablation by disrupting mitochondria and triggering cell death in cardiomyocytes. The findings refine mechanistic understanding and establish quantitative parameters for effective, non-thermal cardiac ablation, offering crucial guidance for translational research and therapeutic innovation.

16426 records 1/1096 page Next 12345 下5页 Last page